Martingale Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,400
Closed -$274K 800
2023
Q3
$274K Hold
1,400
0.01% 701
2023
Q2
$294K Hold
1,400
0.01% 699
2023
Q1
$283K Sell
1,400
-395
-22% -$79.7K 0.01% 717
2022
Q4
$391K Sell
1,795
-752
-30% -$164K 0.01% 672
2022
Q3
$502K Sell
2,547
-53,981
-95% -$10.6M 0.01% 622
2022
Q2
$12.1M Sell
56,528
-5,086
-8% -$1.09M 0.22% 129
2022
Q1
$17.5M Sell
61,614
-6,586
-10% -$1.87M 0.26% 131
2021
Q4
$25.7M Sell
68,200
-7,000
-9% -$2.64M 0.33% 116
2021
Q3
$31M Sell
75,200
-16,013
-18% -$6.61M 0.41% 100
2021
Q2
$33.7M Buy
91,213
+4,899
+6% +$1.81M 0.39% 99
2021
Q1
$25M Buy
86,314
+4,370
+5% +$1.27M 0.29% 124
2020
Q4
$20.5M Buy
81,944
+34,684
+73% +$8.67M 0.23% 133
2020
Q3
$10.7M Buy
47,260
+39,655
+521% +$8.98M 0.13% 163
2020
Q2
$1.33M Buy
7,605
+2,600
+52% +$454K 0.02% 659
2020
Q1
$633K Buy
+5,005
New +$633K 0.01% 772